Today we Cover $WALD, $HYZN, $DNA, and more… While De-SPACs may have seemed like easy targets for short-sellers a few months ago, the combination of strong results and great execution has made it a very costly bet. As the Q3 earnings season continues, a biotechnology company and a hydrogen
Subscribe To Our Newsletter 💰
Which SPAC will send your portfolio the moon?
Sign up for our free newsletter to find out. 🚀